Vertebral angiomatosis in cats is a rare locally aggressive benign tumor-like lesion that has been reported to have a good prognosis if surgically treated. This case reports a 14-month-old Maine Coon cat, who had a successful surgery for vertebral angiomatosis at the age of seven months, and represented with hindlimb ambulatory paraparesis seven months after the surgery. The CT scan confirmed the recurrence of vertebral angiomatosis, seven months postsurgery, showing more aggressive characteristics than the initial lesion and a poorer prognosis.
An 11-year-old cat presented with a 10-day history of anorexia and jaundice. Diagnostic examinations showed hyperbilirubinemia, dilatation of the bile ducts and a mural mass in the common bile duct. Cholecystoduodenostomy, mass resection and end-to-end anastomosis of the common bile duct were performed. Histopathology revealed a well-differentiated cholangiocarcinoma. The cat improved clinically and had a good quality of life for 16 months prior to disease recurrence. Liver biopsy indicated metastasis of the primary tumour. Euthanasia was elected. Cholangiocarcinoma in cats is considered to have a poor prognosis with high rate of metastasis. Given the paucity of information in the veterinary literature and the lack of specific prognostic indicators, guidelines for feline cholangiocarcinoma management have not been fully established. This clinical case report describes an acceptable outcome after tumour resection and biliary diversion in an 11-year-old cat with extrahepatic cholangiocarcinoma and no pre-existing metastases.
INVESTIGATIONSAbdominal ultrasound (US) indicated severe generalized hepatomegaly with multiple tubular/round, anechoic structures
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.